纽瑞克斯制药 NRIX
$15.30 +$0.46 (+3.10%)
休市 · Nov 7, 5:10 am ET · 最新盘后价 $15.07 -1.50%
开盘$15.10
昨收$14.84
当日区间$14.79 – $15.52
成交量2.98M
市值$1.67B
市盈率（TTM）6.3
股息率–
基本面
最新报告季度：Q3, ended Aug 2026
营收$673.06M+8,426.3% YoY
营业利润$559.45M+712.2% YoY
净利润$549.81M+736.2% YoY
摊薄每股收益$4.73+559.2% YoY
自由现金流$614.24M+1,122.1% YoY
经营现金流$615.63M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率41.3%
净利率42.0%
净资产收益率44.0%
资产收益率34.3%
投入资本回报率37.9%
流动比率8.44
负债/资产比率19.0%
现金及投资$1.05B
总负债$62.09M
净现金（净负债）$986.16M
自由现金流/营收52.7%
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $673.06M | $9.04M | $6.25M | $83.98M | $13.58M |
| 营业总收入 | $673.06M | $9.04M | $6.25M | $83.98M | $13.58M |
| 营业费用 | $113.61M | $103.25M | $98.75M | $369.65M | $96.67M |
| 销售及管理费用 | $34.35M | $15.59M | $14.61M | $52.74M | $13.65M |
| -管理费用 | $34.35M | $15.59M | $14.61M | $52.74M | $13.65M |
| 研发费用 | $79.26M | $87.65M | $84.14M | $316.90M | $83.02M |
| 营业利润 | $559.45M | -$94.20M | -$92.50M | -$285.67M | -$83.10M |
| 非经营性利息净收入（支出） | $3.96M | $4.40M | $5.32M | $21.97M | $4.87M |
| 非经营性利息收入 | $3.96M | $4.40M | $5.32M | $21.97M | $4.87M |
| 税前利润 | $563.41M | -$89.81M | -$87.17M | -$263.70M | -$78.22M |
| 税费 | $13.61M | -$271,000.00 | – | $760,000.00 | $0.00 |
| 净利润 | $549.81M | -$89.54M | -$87.17M | -$264.46M | -$78.22M |
| 持续经营利润 | $549.81M | -$89.54M | -$87.17M | -$264.46M | -$78.22M |
| 归属母公司净利润 | $549.81M | -$89.54M | -$87.17M | -$264.46M | -$78.22M |
| 归属普通股股东净利润 | $549.81M | -$89.54M | -$87.17M | -$264.46M | -$78.22M |
| 基本每股收益 | $4.93 | -$0.81 | -$0.79 | -$3.05 | -$0.82 |
| 摊薄每股收益 | $4.73 | -$0.81 | -$0.79 | -$3.05 | -$0.82 |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $1.20B | $535.54M | $636.13M | $688.14M | $688.14M |
| 流动资产合计 | $1.10B | $456.48M | $554.39M | $606.82M | $606.82M |
| 现金及现金等价物与短期投资 | $1.05B | $443.53M | $540.73M | $592.94M | $592.94M |
| -现金及现金等价物 | $720.24M | $67.69M | $71.20M | $246.96M | $246.96M |
| -短期投资 | $328.01M | $375.84M | $469.54M | $345.98M | $345.98M |
| 应收款 | $20.00M | – | – | – | – |
| -应收账款 | $20.00M | – | – | – | – |
| 其他流动资产 | $35.44M | $12.95M | $13.66M | $13.88M | $13.88M |
| 非流动资产合计 | $91.61M | $79.06M | $81.74M | $81.32M | $81.32M |
| 固定资产净值 | $68.04M | $70.11M | $73.35M | $73.01M | $73.01M |
| -固定资产原值 | $111.51M | $111.46M | $113.08M | $110.79M | $110.79M |
| -累计折旧 | -$43.47M | -$41.34M | -$39.72M | -$37.78M | -$37.78M |
| 投资及预付款 | $14.83M | – | – | – | – |
| -可供出售证券 | $14.83M | – | – | – | – |
| 其他非流动资产 | $8.74M | $8.95M | $8.38M | $8.31M | $8.31M |
| 负债合计 | $226.99M | $132.91M | $155.24M | $149.39M | $149.39M |
| 流动负债合计 | $130.74M | $72.02M | $92.20M | $86.47M | $86.47M |
| 应付款 | $46.93M | $12.46M | $11.33M | $12.27M | $12.27M |
| -应付账款 | $32.98M | $12.21M | $10.29M | $11.22M | $11.22M |
| -应付税款合计 | $13.95M | $247,000.00 | $1.04M | $1.06M | $1.06M |
| 一年内应计费用 | $27.98M | $28.27M | $31.12M | $30.16M | $30.16M |
| 短期债务及融资租赁负债 | $3.24M | $3.22M | $3.20M | $2.82M | $2.82M |
| -一年内到期融资租赁负债 | $3.24M | $3.22M | $3.20M | $2.82M | $2.82M |
| 一年内递延负债 | $30.84M | $13.32M | $18.75M | $17.58M | $17.58M |
| 其他流动负债 | $1.49M | $1.30M | $1.93M | $2.10M | $2.10M |
| 非流动负债合计 | $96.25M | $60.89M | $63.04M | $62.92M | $62.92M |
| 长期债务及融资租赁负债 | $62.09M | $54.92M | $55.45M | $52.91M | $52.91M |
| -长期融资租赁负债 | $62.09M | $54.92M | $55.45M | $52.91M | $52.91M |
| 一年以上递延负债 | $34.15M | $5.97M | $7.59M | $10.01M | $10.01M |
| 股东权益合计 | $968.31M | $402.63M | $480.89M | $538.75M | $538.75M |
| 股东权益 | $968.31M | $402.63M | $480.89M | $538.75M | $538.75M |
| 股本 | $109,000.00 | $104,000.00 | $103,000.00 | $102,000.00 | $102,000.00 |
| -普通股 | $109,000.00 | $104,000.00 | $103,000.00 | $102,000.00 | $102,000.00 |
| -优先股 | $0.00 | $0.00 | – | $0.00 | $0.00 |
| 资本公积 | $1.60B | $1.58B | $1.57B | $1.54B | $1.54B |
| 留存收益 | -$630.13M | -$1.18B | -$1.09B | -$1.00B | -$1.00B |
| 不影响留存收益的损益 | -$210,000.00 | -$145,000.00 | $56,000.00 | $105,000.00 | $105,000.00 |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $615.63M | -$96.57M | -$71.91M | -$249.47M | -$67.83M |
| 持续经营经营活动现金流净额 | $615.63M | -$96.57M | -$71.91M | -$249.47M | -$67.83M |
| 持续经营净利润 | $549.81M | -$89.54M | -$87.17M | -$264.46M | -$78.22M |
| 持续经营损益 | $0.00 | $0.00 | $160,000.00 | $89,000.00 | – |
| 折旧、折耗与摊销 | $3.62M | $3.85M | $3.78M | $18.86M | $4.63M |
| 营运资金变动 | $52.37M | -$20.72M | $3.90M | -$31.60M | -$1.55M |
| -应收款变动 | -$20.00M | – | – | – | – |
| -预付资产变动 | -$13.56M | $263,000.00 | $1.29M | -$6.23M | -$1.28M |
| -应付账款及应计费用变动 | $41.04M | -$13.38M | $3.66M | $16.68M | $14.07M |
| -其他流动负债变动 | -$809,000.00 | -$557,000.00 | $205,000.00 | -$5.07M | -$756,000.00 |
| -其他营运资金变动 | $45.70M | -$7.04M | -$1.25M | -$36.98M | -$13.58M |
| 投资活动现金流净额 | $31.58M | $93.00M | -$123.83M | $147.85M | $346,000.00 |
| 持续经营投资活动现金流净额 | $31.58M | $93.00M | -$123.83M | $147.85M | $346,000.00 |
| 固定资产购置及出售净额 | -$1.39M | -$1.94M | -$1.05M | -$14.00M | -$5.13M |
| 投资购置及出售净额 | $32.97M | $94.93M | -$122.78M | $161.86M | $5.48M |
| 筹资活动现金流 | $5.16M | $66,000.00 | $19.98M | $238.64M | $236.01M |
| 持续经营筹资活动现金流净额 | $5.16M | $66,000.00 | $19.98M | $238.64M | $236.01M |
| 普通股发行净额 | $0.00 | $0.00 | $18.00M | $234.76M | $234.76M |
| 股票期权行使所得 | $5.16M | $66,000.00 | $1.97M | $3.88M | $1.25M |
| 期末现金余额 | $721.02M | $68.65M | $72.16M | $247.93M | $247.93M |
| 现金净变动 | $652.37M | -$3.51M | -$175.77M | $137.03M | $168.52M |
| 期初现金余额 | $68.65M | $72.16M | $247.93M | $110.90M | $79.41M |
| 自由现金流 | $614.24M | -$98.51M | -$72.96M | -$263.47M | -$72.96M |
暂无评论——快来第一个聊聊 NRIX。